Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56626 - 56650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	RUNX1T1	862	upregulated	panobinostat results in increased expression of RUNX1T1 mRNA	8q21.3	A21037
Panobinostat	Approved Investigational	RUNX3	864	upregulated	panobinostat results in increased expression of RUNX3 mRNA	1p36.11	A21037
Panobinostat	Approved Investigational	RYR3	6263	downregulated	panobinostat results in decreased expression of RYR3 mRNA	15q13.3-q14	A21037
Panobinostat	Approved Investigational	S100A10	6281	upregulated	panobinostat results in increased expression of S100A10 mRNA	1q21.3	A21037
Panobinostat	Approved Investigational	S100A11	6282	upregulated	panobinostat results in increased expression of S100A11 mRNA	1q21.3	A21037
Panobinostat	Approved Investigational	S100A11P1	729659	upregulated	panobinostat results in increased expression of S100A11P1 mRNA	7q22.1	A21037
Panobinostat	Approved Investigational	S100A4	6275	upregulated	panobinostat results in increased expression of S100A4 mRNA	1q21.3	A21037
Panobinostat	Approved Investigational	S100A6	6277	upregulated	panobinostat results in increased expression of S100A6 mRNA	1q21.3	A21037
Panobinostat	Approved Investigational	S100B	6285	upregulated	panobinostat results in increased expression of S100B mRNA	21q22.3	A21037
Panobinostat	Approved Investigational	S1PR3	1903	downregulated	panobinostat results in decreased expression of S1PR3 mRNA	9q22.1	A21037
Panobinostat	Approved Investigational	S1PR5	53637	upregulated	panobinostat results in increased expression of S1PR5 mRNA	19p13.2	A21037
Panobinostat	Approved Investigational	SALL2	6297	downregulated	panobinostat results in decreased expression of SALL2 mRNA	14q11.2	A21037
Panobinostat	Approved Investigational	SALL3	27164	downregulated	panobinostat results in decreased expression of SALL3 mRNA	18q23	A21037
Panobinostat	Approved Investigational	SAT1	6303	upregulated	panobinostat results in increased expression of SAT1 mRNA	Xp22.11	A21037
Panobinostat	Approved Investigational	SBF2	81846	upregulated	panobinostat results in increased expression of SBF2 mRNA	11p15.4	A21037
Panobinostat	Approved Investigational	SCCPDH	51097	downregulated	panobinostat results in decreased expression of SCCPDH mRNA	1q44	A21037
Panobinostat	Approved Investigational	SCG3	29106	upregulated	panobinostat results in increased expression of SCG3 mRNA	15q21.2	A21037
Panobinostat	Approved Investigational	SCGB3A2	117156	upregulated	panobinostat results in increased expression of SCGB3A2 mRNA	5q32	A21037
Panobinostat	Approved Investigational	SCML1	6322	upregulated	panobinostat results in increased expression of SCML1 mRNA	Xp22.13	A21037
Panobinostat	Approved Investigational	SCN4B	6330	upregulated	panobinostat results in increased expression of SCN4B mRNA	11q23.3	A21037
Panobinostat	Approved Investigational	SCN7A	6332	downregulated	panobinostat results in decreased expression of SCN7A mRNA	2q24.3	A21037
Panobinostat	Approved Investigational	SCNN1A	6337	upregulated	panobinostat results in increased expression of SCNN1A mRNA	12p13	A21037
Panobinostat	Approved Investigational	SCNN1G	6340	upregulated	panobinostat results in increased expression of SCNN1G mRNA	16p12.2	A21037
Panobinostat	Approved Investigational	SCRG1	11341	upregulated	panobinostat results in increased expression of SCRG1 mRNA	4q34.1	A21037
Panobinostat	Approved Investigational	SCUBE2	57758	downregulated	panobinostat results in decreased expression of SCUBE2 mRNA	11p15.4	A21037

Displaying entries 56626 - 56650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability